blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0684997

EP0684997 - ANTHRAX TOXIN FUSION PROTEINS AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.06.1999
Database last updated on 25.09.2024
Most recent event   Tooltip19.09.2003Lapse of the patent in a contracting state
New state(s): DK
published on 05.11.2003  [2003/45]
Applicant(s)For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute of Health, Office of Technology Transfer, Westwood Building, Box OTT
Bethesda, MD 20892-9902 / US
[N/P]
Former [1995/49]For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute of Health, Office of Technology Transfer, Westwood Building, Box OTT
Bethesda, MD 20892-9902 / US
Inventor(s)01 / LEPPLA, Stephen H.
5612 Alta Vista Road
Bethesda, MD 20817 / US
02 / KLIMPEL, Kurt
23816 Woodfield Road
Gaithersburg, MD 20882 / US
03 / ARORA, Naveen
G 110 Ashok Vihar, Phase I
Delhi 110052 / IN
04 / SINGH, Yogendra, SCIR Center for Biochemicals
University of Delhi, Mall Road
Delhi 110007 / IN
[1998/34]
Former [1995/49]01 / LEPPLA, Stephen H.
5612 Alta Vista Road
Bethesda, MD 20817 / US
02 / KLIMPEL, Kurt
23816 Woodfield Road
Gaithersburg, MD 20882 / US
03 / ARORA, Naveen
G 110 Ashok Vihar, Phase I
Delhi 110052 / IN
04 / SINGH, Yogendra, SCIR Center for Biochemicals
University of Delhi, Mall Road
Delhi 110007 / IN
05 / NICHOLS, Peter J., 40 Axminster Crecent
Welling
Kent DA16 1HG / GB
Representative(s)Thomson, Paul Anthony, et al
Potts, Kerr & Co. 15, Hamilton Square Birkenhead
Merseyside CH41 6BR / GB
[N/P]
Former [1995/49]Thomson, Paul Anthony, et al
Potts, Kerr & Co. 15, Hamilton Square
Birkenhead Merseyside L41 6BR / GB
Application number, filing date94911385.614.02.1994
[1995/49]
WO1994US01624
Priority number, dateUS1993002160112.02.1993         Original published format: US 21601
US1993008284925.06.1993         Original published format: US 82849
[1995/49]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9418332
Date:18.08.1994
[1994/19]
Type: A1 Application with search report 
No.:EP0684997
Date:06.12.1995
Language:EN
The application published by WIPO in one of the EPO official languages on 18.08.1994 takes the place of the publication of the European patent application.
[1995/49]
Type: B1 Patent specification 
No.:EP0684997
Date:19.08.1998
Language:EN
[1998/34]
Search report(s)International search report - published on:EP13.10.1994
ClassificationIPC:C12N15/62, C12N15/85, C12N15/32, C07K14/00, A61K39/02, A61K38/00
[1998/34]
CPC:
C07K14/005 (EP,US); A61K47/6425 (EP,US); C07K14/21 (EP,US);
C07K14/32 (EP,US); C07K16/00 (EP,US); C07K19/00 (EP,US);
C12N15/62 (EP,US); A61K38/00 (EP,US); C07K2317/77 (EP,US);
C07K2319/00 (EP,US); C07K2319/55 (EP,US); C12N2740/13022 (EP,US);
C12N2740/16222 (EP,US) (-)
Former IPC [1995/49]C12N15/62, C12N15/85, C12N15/32, C07K13/00, A61K39/02, A61K37/02
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1995/49]
TitleGerman:ANTHRAX-TOXIN-FUSIONSPROTEINE UND DEREN VERWENDUNGEN[1995/49]
English:ANTHRAX TOXIN FUSION PROTEINS AND USES THEREOF[1995/49]
French:PROTEINES DE FUSION DE LA TOXINE DU BACILLE DU CHARBON ET LEURS UTILISATIONS[1995/49]
Entry into regional phase19.08.1995National basic fee paid 
19.08.1995Designation fee(s) paid 
19.08.1995Examination fee paid 
Examination procedure17.08.1994Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.08.1995Examination requested  [1995/49]
07.06.1996Despatch of a communication from the examining division (Time limit: M06)
11.12.1996Reply to a communication from the examining division
30.01.1997Despatch of a communication from the examining division (Time limit: M04)
03.06.1997Reply to a communication from the examining division
14.08.1997Despatch of communication of intention to grant (Approval: Yes)
26.01.1998Communication of intention to grant the patent
20.04.1998Fee for grant paid
20.04.1998Fee for publishing/printing paid
Opposition(s)20.05.1999No opposition filed within time limit [1999/32]
Fees paidRenewal fee
25.01.1996Renewal fee patent year 03
17.01.1997Renewal fee patent year 04
26.01.1998Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipGR19.08.1998
DK19.11.1998
PT19.11.1998
[2003/45]
Former [2001/23]GR19.08.1998
PT19.11.1998
Former [1999/29]PT19.11.1998
Cited inInternational search[X]  - NAVEEN ARORA ET AL., "Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells", JOURNAL OF BIOLOGICAL CHEMISTRY, BALTIMORE, MD US, (19920805), vol. 267, no. 22, pages 15542 - 15548 [X] 1-3,8-10 * abstract * * page 15542, column R, paragraph L - page 15543, column L, paragraph 2 * * page 15544, column R, paragraph 2 * * page 15547, column R, paragraph 2 - paragraph 3 *
 [X]  - N. ARORA ET AL., "Potent hybrid cytotoxins of anrhrax lethal factor and the ADP-ribosylation domain of Pseudomonas exotoxin A are translocated directly to the cytosol of mammalian cells", ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON US, (1992), page 31 [X] 1-3,8-10 * see abstract n. B-33 *
 [A]  - ANGEL CATALDI ET AL., "Regulation of pag gene expression in Bacillus anthracis: Use of a pag-lacZ transcriptional fusion", FEMS MICROBIOLOGY LETTERS, (19921101), vol. 98, no. 1-3, pages 89 - 94 [A] 11,15-17 * page 89, column L, paragraph 1 * * page 90, column L, paragraph L * * page 90, column R, paragraph 4 *
 [A]  - KURT R. KLIMPEL ET AL., "Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., WASHINGTON US, (19921101), vol. 89, no. 21, pages 10277 - 10281 [A] 32,38 * abstract * * page 10278, column R, paragraph 2 - page 10279, column L, paragraph 3 * * page 10280, column L, paragraph 2 - column R, paragraph 3 *
 [PX]  - NAVEEN ARORA ET AL., "Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides", JOURNAL OF BIOLOGICAL CHEMISTRY, BALTIMORE, MD US, (19930215), vol. 268, no. 5, pages 3334 - 3341 [PX] 1-3,8-10 * abstract * * page 3335, column L, paragraph 2 * * page 3336, column L, paragraph L - column R, paragraph 2 * * page 3336, column R, paragraph 5 - page 3337, column R, paragraph 1 * * page 3340, column L, paragraph 2 * * page 3340, column R, paragraph 2 - page 3341, column L, paragraph 1 *
 [PX]  - KURT R. KLIMPEL ET AL., "Modified anthrax toxin is cleaved and activated by HIV-1 protease", JOURNAL OF CELLULAR BIOCHEMISTRY, (1994), vol. 18B, page 163 [PX] 32-41 * see abstract n. J 515 *
by applicant   - YOKOTA ET AL., CANCER RES, (1992), vol. 52, page 3402
    - COLCHER ET AL., NATL.CANCER INST., (1990), vol. 82, page 1191
    - MILENIC ET AL., CANCER RES., (1991), vol. 51, page 6363
    - HUSTON ET AL., METHODS ENZYMOL., (1991), vol. 203, page 46
    - JOHNSON, S.; BIRD, R. E., METHODS ENZYMOL., (1991), vol. 203, page 88
    - BLAUSTEIN ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1989), vol. 86, pages 2209 - 2213
    - KOEHLER, T. M.; COLLIER, R.J., MOL. MICROBIOL., (1991), vol. 5, pages 1501 - 1506
    - FRIEDLANDER, A. M., J. BIOL. CHEM., (1986), vol. 261, pages 7123 - 7126
    - GORDON ET AL., J. BIOL. CHEM., (1989), vol. 264, pages 14792 - 14796
    - GORDON ET AL., INFECT. IMMUN., (1988), vol. 56, pages 1066 - 1069
    - LEPPLA, S. H., PROC. NATL. ACAD. SCI. U.S.A., (1982), vol. 79, pages 3162 - 3166
    - P. MIKESELL ET AL., "Evidence for plasmid-mediated toxin production in Bacillus anthracis", INFECT. IMMUN., (1983), vol. 39, pages 371 - 376
 US19930042745
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.